stockrow
Friday 6 November 2026
Export HTFL’s income statement to Excel — free account
Heartflow, Inc.
HTFL Healthcare Health Information Services
Heartflow, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $176.0 million, up 39.9% from fiscal 2024.
- Revenue
- +47.6%
- EPS
- +87.7%
- Free cash flow
- +62.6%
Quarter to June 2026, against a year earlier
52.09
0.14
+0.27%
Follow HTFL
Alert me
Heartflow, Inc. (HTFL) Revenue
Heartflow, Inc.'s revenue for fiscal 2025 was $176.0M, up 39.9% from $125.8M in fiscal 2024. Over the twelve months to 30 June 2026 it was $212.1M. Heartflow, Inc. ranks 22nd of 42 Health Information Services companies by revenue.
Revenue, annual
Embed this chart
Annual newest first
| Period | Revenue | Change |
|---|---|---|
| FY2025 | $176.0M | 39.92% |
| FY2024 | $125.8M | 44.32% |
| FY2023 | $87.2M | — |
Quarterly newest first
| Period | Revenue | Change |
|---|---|---|
| Jun 2026 | $64.1M | 21.86% |
| Mar 2026 | $52.6M | 7.04% |
| Dec 2025 | $49.1M | 6.17% |
| Sep 2025 | $46.3M | 6.57% |
| 6 more quarters | Free account |
Revenue against peers
| Company | Revenue |
|---|---|
| TDOC Teladoc Health, Inc. compare | $2.5B |
| PRVA Privia Health Group, Inc. compare | $2.4B |
| HQY HealthEquity, Inc. compare | $1.4B |
| WAY Waystar Holding Corp. compare | $1.3B |
| OMCL Omnicell, Inc. compare | $1.2B |
| HNGE Hinge Health Inc. compare | $720.1M |
| DOCS Doximity, Inc. compare | $661.6M |
| SDGR Schrodinger, Inc. compare | $269.2M |
| HTFL Heartflow, Inc. | $212.1M |
What Revenue is
Revenue tells an investor how much a company brought in from selling its goods and services over a period, before any costs are taken out.
Reported line item
More on HTFL
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- The full statement